Hyaluronic acid product developer IBSA Italia and energy-based medical and aesthetic manufacturer Alma have announced an agreement of strategic partnership.
As part of the partnership, the companies will aim to promote what they call ‘a new approach to aesthetic medicine’, aimed at wellbeing and maintaining the tissues involved in the ageing process.
“Recent global trends in aesthetic medicine show an increasing focus on the subject of regenerative medicine and a growing orientation towards standards of excellence that aim to obtain a ‘natural’ end result, without changing individual somatic traits,” said Eyal Ben David, vice president global sales, Alma Lasers International, adding, “Many energy-based device treatments are part of skin rejuvenation programmes that generally also include the use of hyaluronic acid based injectables. The combined use of these treatments, which are applied according to standardised protocols, offers better and immediate results with the added advantage of being minimally invasive and not very painful for the patient. It is precisely in this effective synergy, as well as in the sharing of a new approach to aesthetic medicine, that the value of the partnership between Alma and IBSA comes from.”
Tania Pirazzini, licensing and BU dermoaesthetic director, IBSA Farmaceutici Italia, added, “The partnership with Alma Lasers comes from the sharing of a new approach to aesthetic medicine, which should be understood increasingly as a path for prevention and treatment that accompanies the patient for a number of years. The common vision we have is that of promoting a holistic, non-surgical approach, based on the integration of different regenerative methods aimed at improving people’s complete well-being. To do this, IBSA and Alma provide their cutting-edge technologies to healthcare professionals.”
The companies have confirmed that a clinical study will start in September at the University of Modena and Reggio-Emilia to examine the combination of IBSA’s hyaluronic acid-based solutions with Alma’s energy-based solutions.
